🔎 Trials Near Me

Home › Kanser sa Traktong Biliary › Virginia

Pag-aaral pangklinika para sa Kanser sa Traktong Biliary sa Virginia

9 pag-aaral para sa Kanser sa Traktong Biliary ang naghahanap ng mga kalahok sa mga site sa Virginia.

Mga Lungsod sa Virginia

Opisyal na teksto ng pag-aaral (English)

A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

  • Oncology and Hematology Associates of Southwest Virginia (BRCC) ( Site 0295), Roanoke
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06428409

Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer

  • Virginia Commonwealth University, VCU Health, Richmond
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT06282575

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

  • Virginia Cancer Specialists, Fairfax
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT06293898

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

  • Avenzo Therapeutics Recruiting Site, Fairfax
Nagre-recruitPhase 1/2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07038343

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

  • Inova Schar Cancer Institute, Falls Church
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 21, 2026 · NCT06774963

Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer

  • Research Site, Fairfax
Nagre-recruitPhase 3
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT06467357

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

  • Virginia Cancer Specialists, Fairfax
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT06330064

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

  • NEXT Virginia, Fairfax
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT07458347

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.